XL Congresso Società Italiana di Neurologia PADOVA 21-25 ...

22
N
O
V
E
M
B
R
E
•
A
R
E
A
P
O
S
T
E
R
DIFFERENCES BETWEEN BETA-INTERFERONS, GLATIRAMER ACETATE
AND NATALIZUMAB
S. MASERA, A. MATTIODA, A. FASANO, V. CARROZZO, C. CONDELLO, A. ROMAGNOLO,
A. MEROLA, M. VERCELLINO, P. CAVALLA (Torino)
103. CHRONIC PAROXYSMAL HEMICRANIA INDUCED BY WEEKLY
ADMINISTRATION OF INTERFERON-BETA 1A IN A PATIENT WITH
MULTIPLE SCLEROSIS
C. SENESI, E. DALLABELLA, M. VISCONTI, F. GRANELLA (Parma)
104. ASPIRE (AZATHIOPRINE SECONDARY PROGRESSIVE INTERFERON
TREATED PATIENTS RANDOMISED EVALUATION) STUDY: 2-YEARS
DOUBLE BLIND AND 1-YEAR OPEN, RANDOMIZED, MULTICENTRE,
PILOT STUDY. MULTIPLE SCLEROSIS FUNCTIONAL COMPOSIT (MSFC)
AND MAGNETIC RESONANCE DATA
E. MONTANARI, L. MANNESCHI, I. PESCI, L. MOTTI, E. MERELLI, M. TOLA, D. CAPUTO,
L. PROVINCIALI, E. SCARPINI, M. MARROSU, A. GHEZZI, P. CAVALLA, L. DURELLI
(Fidenza - PR, Reggio Emilia, Modena, Ferrara, Milano, Ancona, Cagliari, Gallarate -
VA, Torino, Orbassano - TO)
105. INSULIN-LIKE GROWTH FACTOR- 1 AND INSULIN LIKE GROWTH
FACTOR BINDING PROTEIN-3 LEVELS IN RELAPSING AND SECONDARY
PROGRESSIVE MS: A LONGITUDINAL STUDY ON IFN-BETA THERAPY
R. LANZILLO, C. DI SOMMA, M. QUARANTELLI, G. VENTRELLA, A. PRINSTER,
A. FERRARO, G. VACCA, G. OREFICE, A. COLAO, V. BRESCIA MORRA (Napoli)
106. DETRIMENTAL EFFECTS OF CYCLOPHOSPHAMIDE ON SEMINAL CELLS
IN MEN WITH MS
S. LO FERMO, S. LA VIGNERA, P. LAISA, S. MESSINA, E. D'AMICO, R. CONDORELLI,
F. CALZAVARA, F. PATTI, E. VICARI, M. ZAPPIA (Catania)
107. SWITCHING TO IMMUNOSUPPRESSANT AGENTS IN SECONDARY
PROGRESSIVE MULTIPLE SCLEROSIS PATIENTS: IS IT REALLY EFFECTIVE?
E. D'AMICO, S. MESSINA, S. LO FERMO, P. LAISA, C. CAMERANO, F. PATTI, M.
ZAPPIA (Catania)
108. THE IMMUNOSUPPRESSANTS TO TREAT MULTIPLE SCLEROSIS: AN
ITALIAN MULTICENTRIC STUDY
F. PATTI, C. POZZILLI, A. LUGARESI, E. MILLEFIORINI, R. BERGAMASCHI, G. LUS,
D. MAIMONE, M. VIANELLO, G. CONIGLIO, G. TEDESCHI, P. GALLO, G. DI BATTISTA,
P. L AISA, D. LEPORE, D. CORRADO, G. COMI, M. TROJANO (Catania, Chieti, Roma,
Pavia, Napoli, Treviso, Potenza, Padova, Santa Maria Imbaro - CH, Milano, Bari)
109. STEROID-RELATED HYPERTRANSAMINASEMIA FOLLOWING TREATMENT
FOR MULTIPLE SCLEROSIS RELAPSES: A DESCRIPTION OF FOUR CASES
D. FERRARO, V. MIRANTE, E. VILLA, A. SIMONE, P. SOLA (Modena)
110. ECONOMETRIC EVALUATION OF THERAPEUTIC COMPLIANCE TO
DISEASE MODIFYING DRUGS IN PATIENTS WITH MULTIPLE SCLEROSIS
L. DE SANTI, G. POLIMENI, E. PALELLA, F. LA FAUCI BELPONER, E. SESSA, P. BRAMANTI,
L. GITTO (Messina, Roma)
111. QUALITY OF LIFE IN MULTIPLE SCLEROSIS PATIENTS TREATED WITH
NATALIZUMAB: EVALUATION AFTER ONE YEAR TREATMENT
M. ZAFFARONI, P. ANNOVAZZI, A. RIZZO, S. BALDINI, A. GHEZZI, G. COMI
(Gallarate - VA, Milano)
112. A 10 YEAR FOLLOW-UP STUDY OF TREATMENT WITH INTERFERONS
IN MULTIPLE SCLEROSIS
P. BELLANTONIO, F. DI BIASIO, G. AMATRUDO, A. VELLUCCI, D. IAPAOLO, F. LENA,
A. BRUNETTI, N. MODUGNO, S. PIETRACUPA, S. RUGGIERI (Pozzilli - IS)
148